These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 26344366)
21. High-density lipoprotein-biomimetic nanocarriers for glioblastoma-targeting delivery: the effect of shape. Huang JL; Jiang G; Song QX; Gu X; Song HH; Wang XL; Jiang D; Kang T; Feng XY; Jiang XG; Chen HZ; Gao XL Pharmazie; 2016 Dec; 71(12):709-714. PubMed ID: 29441999 [TBL] [Abstract][Full Text] [Related]
22. [Construction of artesunate nanoparticles modified by hyaluronic acid and cell-penetrating peptides and its inhibitory effect on cancer cells in vitro]. Li J; Jin S; Dong XR; Han XF; Wang MY Zhongguo Zhong Yao Za Zhi; 2018 Sep; 43(18):3668-3675. PubMed ID: 30384531 [TBL] [Abstract][Full Text] [Related]
23. Polymer Nanoparticles Modified with Photo- and pH-Dual-Responsive Polypeptides for Enhanced and Targeted Cancer Therapy. Yang Y; Xie X; Yang Y; Li Z; Yu F; Gong W; Li Y; Zhang H; Wang Z; Mei X Mol Pharm; 2016 May; 13(5):1508-19. PubMed ID: 27043442 [TBL] [Abstract][Full Text] [Related]
24. Lipoprotein-mimicking nanotherapeutics reconstituted with chenodeoxycholic acid modified protein for efficient tumor targeting. Hu Y; Zou J; Wang Q; Chen Y; Wang H; Li J Eur J Pharm Biopharm; 2024 Mar; 196():114184. PubMed ID: 38244896 [TBL] [Abstract][Full Text] [Related]
25. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery. Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890 [TBL] [Abstract][Full Text] [Related]
26. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517 [TBL] [Abstract][Full Text] [Related]
27. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier. Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747 [TBL] [Abstract][Full Text] [Related]
28. Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins. Wang J; Jia J; Liu J; He H; Zhang W; Li Z Drug Deliv; 2013 Nov; 20(8):356-63. PubMed ID: 24079327 [TBL] [Abstract][Full Text] [Related]
29. pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer. Wan X; Liu C; Lin Y; Fu J; Lu G; Lu Z Drug Deliv; 2019 Dec; 26(1):470-480. PubMed ID: 30957572 [TBL] [Abstract][Full Text] [Related]
30. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery. Wang G; Maciel D; Wu Y; Rodrigues J; Shi X; Yuan Y; Liu C; Tomás H; Li Y ACS Appl Mater Interfaces; 2014 Oct; 6(19):16687-95. PubMed ID: 25167168 [TBL] [Abstract][Full Text] [Related]
31. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. Yang Y; Yang L; You QD; Nie FF; Gu HY; Zhao L; Wang XT; Guo QL Cancer Lett; 2007 Oct; 256(2):259-66. PubMed ID: 17693016 [TBL] [Abstract][Full Text] [Related]
32. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells. Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684 [TBL] [Abstract][Full Text] [Related]
33. Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis. Lyu L; Huang LQ; Huang T; Xiang W; Yuan JD; Zhang CH Drug Des Devel Ther; 2018; 12():743-756. PubMed ID: 29670331 [TBL] [Abstract][Full Text] [Related]
34. Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxel. He H; Chen S; Zhou J; Dou Y; Song L; Che L; Zhou X; Chen X; Jia Y; Zhang J; Li S; Li X Biomaterials; 2013 Jul; 34(21):5344-58. PubMed ID: 23591391 [TBL] [Abstract][Full Text] [Related]
35. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles. Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637 [TBL] [Abstract][Full Text] [Related]
36. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity. Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850 [TBL] [Abstract][Full Text] [Related]
37. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853 [TBL] [Abstract][Full Text] [Related]
38. Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids. Mo R; Sun Q; Li N; Zhang C Biomaterials; 2013 Apr; 34(11):2773-86. PubMed ID: 23352118 [TBL] [Abstract][Full Text] [Related]
39. Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment. Zhang Z; Qian H; Yang M; Li R; Hu J; Li L; Yu L; Liu B; Qian X Int J Nanomedicine; 2017; 12():1593-1605. PubMed ID: 28280328 [TBL] [Abstract][Full Text] [Related]
40. Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells. Li C; Qi Q; Lu N; Dai Q; Li F; Wang X; You Q; Guo Q Biochem Cell Biol; 2012 Dec; 90(6):718-30. PubMed ID: 23194187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]